To accelerate the development of, and access to, psychedelic drugs that could save lives and reverse the crisis of serious mental illness in the United States, and for other purposes.

Committees

• PrimaryVeterans' Affairs Committee
• AlsoJudiciary Committee
• AlsoEnergy and Commerce Committee

Action history

1. June 30, 2026Introduced in House
2. June 30, 2026Introduced in House
3. June 30, 2026Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
4. June 30, 2026Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
5. June 30, 2026Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Cosponsors (3)

• Rep. Bergman, Jack [R-MI-1]MI-01
• Rep. Correa, J. Luis [D-CA-46]CA-46
• Rep. McCaul, Michael T. [R-TX-10]TX-10